A phase I trial of high dose gefitinib for patients with leptomeningeal metastases from non-small cell lung cancer.

Jackman DM, Cioffredi LA, Jacobs L, Sharmeen F, Morse LK, Lucca J, Plotkin SR, Marcoux PJ, Rabin MS, Lynch TJ, Johnson BE, Kesari S

Open source

DOI: 10.18632/oncotarget.2886
Published: 2015 Feb 28
Container: Oncotarget
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.18632/oncotarget.2886,
  title = {A phase I trial of high dose gefitinib for patients with leptomeningeal metastases from non-small cell lung cancer.},
  author = {Jackman DM and Cioffredi LA and Jacobs L and Sharmeen F and Morse LK and Lucca J and Plotkin SR and Marcoux PJ and Rabin MS and Lynch TJ and Johnson BE and Kesari S},
  year = {2015},
  journal = {Oncotarget},
  doi = {10.18632/oncotarget.2886},
  url = {https://doi.org/10.18632/oncotarget.2886}
}

RIS

TY  - JOUR
TI  - A phase I trial of high dose gefitinib for patients with leptomeningeal metastases from non-small cell lung cancer.
AU  - Jackman DM
AU  - Cioffredi LA
AU  - Jacobs L
AU  - Sharmeen F
AU  - Morse LK
AU  - Lucca J
AU  - Plotkin SR
AU  - Marcoux PJ
AU  - Rabin MS
AU  - Lynch TJ
AU  - Johnson BE
AU  - Kesari S
PY  - 2015
JO  - Oncotarget
DO  - 10.18632/oncotarget.2886
UR  - https://doi.org/10.18632/oncotarget.2886
ER  -

APA

DM, J., LA, C., L, J., F, S., LK, M., J, L., SR, P., PJ, M., MS, R., TJ, L., BE, J., & S, K. (2015). A phase I trial of high dose gefitinib for patients with leptomeningeal metastases from non-small cell lung cancer.. Oncotarget. https://doi.org/10.18632/oncotarget.2886

Source records

pubmed · retrieved 2026-09-27T12:05:16.536Z